Overview

Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disorder

Status:
Withdrawn
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
It is hypothesized that Depakote will be better tolerated then lithium in treating African Americans with bipolar disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Lawson, William B., M.D., PhD, DFAPA
Collaborator:
Abbott
Treatments:
Lithium Carbonate
Valproic Acid